Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / Mar / Bird Flu Biosensor
Microbiology & Immunology Research and Innovations Point of care testing Technology and innovation Biochemistry and molecular biology

Bird Flu Biosensor

Introducing a five-minute test that can detect virus particles in the air expelled from animal housing

03/12/2025 News 1 min read

Share

Credit: Adobe Stock (Edited)

Researchers at Washington University in St Louis, USA, have developed an electrochemical biosensor for the rapid and real-time detection of airborne H5N1 influenza virus. Airborne transmission remains a key concern for highly pathogenic avian influenza H5N1, which has been spreading through poultry, dairy cattle, and wild birds. Traditional detection methods for airborne viruses, like polymerase chain reaction tests, are time-consuming and expensive.

The study, published in ACS Sensors, describes a screen-printed carbon electrode-based capacitive biosensor, designed to detect H5N1 RNA and E. coli DNA in aerosols within five minutes. The carbon is coated with a combination of graphene oxide and Prussian blue nanocrystals to increase the biosensor's sensitivity and stability, allowing for the detection of extremely low concentrations of pathogens. Aptamer “capture probes” – made from single strands of DNA – bind to virus proteins in the air flowing over the sensor, flagging them to the sensor.

During laboratory validation, the biosensor achieved detection limits as low as 56 copies of H5N1 RNA per milliliter of air and five E. coli cells per milliliter. The system achieved an overall accuracy of >90 percent for detection of airborne pathogen samples. 

The biosensor can provide concentration ranges of H5N1 in the air and alert operators to disease spikes in real time. Unlike other tests, this biosensor doesn’t require complicated preparation steps, making it easier to use in real-world settings. Another advantage of the system is that it is nondestructive, preserving the viral samples for further analysis by conventional techniques if required.

“This biosensor is specific to H5N1, but it can be adapted to detect other strains of influenza virus (e.g., H1N1) and SARS-CoV-2 as well as bacteria (E. coli and pseudomonas) in the aerosol phase,” said corresponding author Rajan Chakrabarty.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Research and Innovations
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Research Roundup
Research and Innovations
Research Roundup

January 31, 2024

1 min read

From spatial transcriptomics to AI diagnosis, we bring you the latest news in pathology and laboratory medicine

Flexible Solutions With FlexVUE
Research and Innovations
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

Defining the Next Generation of NGS
Research and Innovations
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.